Adipokines and colorectal cancer

Abstract

Chen Yan, Chen Mingwei. Adipokines and colorectal cancer[J]. Journal of International Oncology, 2015, 42(1): 67-70.

［1］刘明月, 臧福才, 唐伟. 肥胖与肿瘤［J］. 国际肿瘤学杂志, 2013, 40(7): 501-503. ［2］ Dalamaga M, Diakopoulos KN, Mantzoros CS. The role of adiponectin in cancer: a review of current evidence［J］. Endocr Rev, 2012, 33(4): 547-594. ［3］ Nakajima TE, Yamada Y, Hamano T, et al. Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer［J］. Cancer Sci, 2010, 101(5): 1286-1291. ［4］ Xu XT, Xu Q, Tong JL, et al. Metaanalysis: circulating adiponectin levels and risk of colorectal cancer and adenoma［J］. J Dig Dis, 2011, 12(4): 234-244. ［5］ Wei EK, Giovannucci E, Fuchs CS, et al. Low plasm adiponectin levels and risk of colorectal cancer in men: a prospective study［J］. J Natl Cancer Inst, 2005, 97(22): 1688-1694. ［6］ Chen MW, Ye S, Zhao LL, et al. Association of palma total and highmolecularweight adiponectin with risk of colorectal cancer: an observational study in Chinese male［J］. Med Oncol, 2012, 29(5): 3129-3135. ［7］ Aleksandrova K, Boeing H, Jenab M, et al. Total and highmolecular weight adiponectin and risk of colorectal cancer: the European prospective investigation into cancer and nutrition study［J］. Carcinogenesis, 2012, 33(6): 1211-1218. ［8］ Song M, Zhang X, Wu K, et al. Plasma adiponectin and soluble leptin receptor and risk of colorectal cancer: a prospective study［J］. Cancer Prev Res (Phila), 2013, 6(9): 875885. ［9］ Moon HS, Liu X, Nagel JM, et al. Salutary effects of adiponectin on colon cancer: in vivo and in vitro studies in mice［J］. Gut, 2013, 62(4): 561-570. ［10］ Sugiyama M, Takahashi H, Hosono K, et al. Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway［J］. Int J Oncol, 2009, 34(2): 339-344. ［11］ Kim AY, Lee YS, Kim KH, et al. Adiponectin represses colon cancer cell proliferation via AdipoR1andR2mediated AMPK activation［J］. Mol Endocrinol, 2010, 24(7): 1441-1452. ［12］ Kim HH, Kim YS, Kang YK, et al. Leptin and peroxisome proliferatoractivated receptor γ expression in colorectal adenoma［J］. World J Gastroenterol, 2012, 18(6): 557-562. ［13］ Paik SS, Jang SM, Jang KS, et al. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma［J］. Ann Surg Oncol, 2009, 16(2): 297-303. ［14］ Aleksandrova K, Boeing H, Jenab M, et al. Leptin and soluble leptin receptor in risk of colorectal cancer in the European prospective investigation into cancer and nutrition cohort［J］. Cancer Res, 2012, 72(20): 5328-5337. ［15］ Cong JC, Dai XW, Shen MY, et al. Expression of obesity hormone leptin in human colorectal cancer［J］. Chin J Cancer Res, 2009, 21(2): 142-146. ［16］ Stachowicz M, Mazurek U, NowakowskaZajdel E, et al. Leptin and its receptors in obese patients with colorectal cancer［J］. J Biol Regul Homeost Agents, 2010, 24(3): 287-295. ［17］ Wang D, Chen J, Chen H, et al. Leptin regulates proliferation and apoptosis of colorectal carcinoma through PI3K/Akt/mTOR signalling pathway［J］. J Biosci, 2012, 37(1): 91-101. ［18］ Aleksandrova K, Boeing H, Jenab M, et al. Leptin and soluble leptin receptor in risk of colorectal cancer in the European prospective investigation into cancer and nutrition cohort［J］. Cancer Res, 2012, 72(20): 5328-5337. ［19］ Jaffe T, Schwartz B. Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signaltransduction pathways［J］. Int J Cancer, 2008, 123(11): 2543-2556. ［20］ Fazeli MS, Dashti H, Akbarzadeh S, et al. Circulating levels of novel adipocytokines in patients with colorectal cancer［J］. Cytokine, 2013, 62(1): 81-85. ［21］ Zhang YY, Zhou LM. Omentin1, a new adipokine, promotes apoptosis through regulating Sirt1dependent p53 deacetylation in hepatocellular carcinoma cells［J］. Eur J Pharmacol, 2013, 698(1-3): 137-144. ［22］ Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin［J］. Science, 2005, 307(5708): 426-430. ［23］ Nakajima TE, Yamada Y, Hamano T, et al. Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer［J］. Cancer Sci, 2010, 101(5): 12861291. ［24］ Nakajima TE, Yamada Y, Hamano T, et al. Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer［J］. J Gastroenterol, 2009, 44(7): 685690. ［25］ Chen M, Wang Y, Li Y, et al. Association of plasma visfatin with risk of colorectal cancer: an observational study of Chinese patients［J］. Asia Pac J Clin Oncol, 2013, In press. ［26］ Huang WS, Chen CN, Sze CI, et al. Visfatin induces stromal cellderived factor1 expression by β1 integrin signaling in colorectal cancer cells［J］. J Cell Physiol, 2013, 228(5): 1017-1024. ［27］ Oita RC, Ferdinando D, Wilson S, et al. Visfatin induces oxidative stress in differentiated C2C12 myotubes in an Aktand MAPKindependent, NFκBdependent manner［J］. Pflugers Arch, 2010, 459(4): 619-630. ［28］ Park JW, Kim WH, Shin SH, et al. Visfatin exerts angiogenic effects on human umbilical vein endothelial cells through the mTOR signaling pathway［J］. Biochim Biophys Acta, 2011, 1813(5): 763-771.

[1]	Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375.
[2]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[3]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285.
[4]	Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan.Research progress on the histopathological growth patterns of colorectal liver metastasis[J]. Journal of International Oncology, 2024, 51(2): 114-118.
[5]	Liu Debao, Sun Ziwen, Lu Shoutang, Xu Haidong.Expression and clinical significance of ASB6 in colorectal cancer tissues[J]. Journal of International Oncology, 2023, 50(8): 470-474.
[6]	Chen Zhuo, Tao Jun, Chen Lin, Ke Jing.Value of detection of peripheral blood miR-194 combined with fecal miR-143 in the clinical screening of colorectal cancer[J]. Journal of International Oncology, 2023, 50(5): 268-273.
[7]	Huang Zhen, Zhang Caiyutian, Ke Shaobo, Shi Wei, Zhao Wensi, Chen Yongshun.Construction of postoperative prognosis model for patients with colorectal cancer[J]. Journal of International Oncology, 2023, 50(3): 157-163.
[8]	Xu Liangfu, Li Yuanfei.Research progress on tumor microenvironment and immune combination therapy of MSS colorectal cancer[J]. Journal of International Oncology, 2023, 50(3): 186-190.
[9]	Liu Yujie, Zhao Zhiqiang, Wang Zicheng.Levels and diagnostic value of TOP2A and ERBB2 in peripheral blood mononuclear cells of patients with early colorectal cancer[J]. Journal of International Oncology, 2023, 50(12): 717-722.
[10]	Tao Hong, Yin Hong, Luo Hong, Tao Jiayu.Potential strategies for targeting tumor-associated macrophages to enhance the efficacy of immune checkpoint inhibitors for colorectal cancer[J]. Journal of International Oncology, 2023, 50(11): 683-687.
[11]	Wang Xi, Wu Chuanqing.Research progress in reversing multidrug resistance in colorectal cancer[J]. Journal of International Oncology, 2023, 50(1): 42-46.
[12]	Gao Yizhao, Liu Yang, Liu Qiulong, Xing Jinliang.Application of circulating cell-free nucleic acid in clinical diagnosis and treatment of colorectal cancer[J]. Journal of International Oncology, 2022, 49(9): 555-559.
[13]	He Zhefeng, Wu Yiyang, Li Zhenjun, Ying Xiaojiang.Predictive value of inflammatory markers in colorectal cancer[J]. Journal of International Oncology, 2022, 49(9): 560-563.
[14]	Zhao Ying, Zhang Gehong.Study on the correlations between AGR, PLR and NLR changes and chemotherapy efficacy of metastatic colorectal cancer[J]. Journal of International Oncology, 2022, 49(8): 473-477.
[15]	Huang Mengpan, Wang Xuehong, Lu Yongfu.Mechanism of FOXA2 in colorectal cancer and its application in diagnosis and treatment[J]. Journal of International Oncology, 2022, 49(8): 490-493.

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments